iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Nifty Pharma stocks continue to rally; Dr. Reddy's, Strides Pharma emerge top gainers

23 Mar 2022 , 12:00 PM

Stock market report with bull and bear
Nifty Pharma stocks continued the rally to lead gains amid volatile trade on Wednesday. Dr. Reddy’sStrides Pharma. Alkem Lab, Pfizer,  and Divis Lab led the gains. Cipla, Granules India and Lupin were trading in the red. Sun Pharma was trading flat.

Sensex and Nifty50 started Wednesday’s session on a positive note tracking three-week highs in other Asian markets following an overnight surge in Wall Street indices. Investors remained focused on news updates about the Russia-Ukraine war and rising coronavirus infections in China.

At around 12.00 noon, BSE Sensex was trading at 58,057.60 up 68.3 points or 0.12% and Nifty 50 at 17,342.80 up 27.30 points or 0.16%. Nifty Pharma was trading at 13,643.70 up 130.55 points or 0.97%, touching a high of 13,725.15 and low of 13,562.30 during intraday trade on Wednesday.

Dr Reddy’s led the gains by surging 3.25% at Rs4,160.85 per piece on Wednesday. Strides Pharma rose 3% at Rs360.50 per piece to outperform. Pfizer (up 2.77%), Alkem Lab (up 2.46%), Gland Pharma (up 2.4%) and Divis Lab (up 2%) was also among the top performers. Torrent Pharma was 1.8% higher.

Cipla shed 1% to drag the most and Granules India and Lupin were down 0.43% and 0.23% respectively. 

Related Tags

  • Aurobindo Pharma share price
  • Biocon share price
  • Cadila Healthcare share price
  • Cipla share price
  • Coronavirus vaccine
  • Covid-19 new cases
  • Covid-19 vaccine
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.